Related Experiment Video
Updated: Aug 2, 2025

The Rigid Tube as an Alternative in Controlling the Problematic Airway
Published on: June 6, 2020
Endoscopic Management of Benign Airway Stenosis in Coronavirus Disease 2019 Patients
Alfonso Fiorelli1, Alfonso Pecoraro2, Giuseppe Failla2
1Thoracic Surgery Unit, Università della Campania "Luigi Vanvitelli", Naples, Italy.
Insights
Endoscopic dilation is effective for benign airway stenosis following coronavirus disease 2019 (COVID-19). COVID-19 infection did not increase stenosis recurrence rates, indicating similar treatment outcomes compared to the general population.
Area of Science:
- Pulmonology
- Gastroenterology
- Critical Care Medicine
Background:
- Benign airway stenosis can occur after coronavirus disease 2019 (COVID-19) infection, often due to prolonged intubation.
- Evaluating endoscopic dilation outcomes in these patients is crucial for understanding treatment efficacy.
- Comparing recurrence rates in COVID-19 patients versus a control group helps determine infection-related risk.
Purpose of the Study:
- To assess the effectiveness of endoscopic dilation for simple benign airway stenosis in COVID-19 patients.
- To determine if COVID-19 infection is associated with a higher rate of stenosis recurrence.
- To identify risk factors for airway stenosis recurrence after endoscopic treatment.
Main Methods:
- An observational, multicenter study included patients with simple benign airway stenosis undergoing endoscopic dilation.
- Follow-up was at least 6 months, comparing outcomes between COVID-19 positive and control groups.
- Univariable and multivariable analyses identified risk factors for recurrence.
Main Results:
- Airway stenosis developed in 71% of patients after COVID-19, frequently linked to prolonged intubation (82%).
- Recurrence rates after the first dilation were similar between COVID-19 (26%) and non-COVID-19 (32%) groups (p=0.70).
- Subglottic stenosis and laser use were significant predictors of recurrence (p<0.05).
Conclusions:
- COVID-19 infection does not negatively impact the outcomes of endoscopic treatment for simple airway stenosis.
- Treatment strategies for airway stenosis in COVID-19 patients should align with those for the general population.
- Endoscopic dilation remains a viable treatment option for benign airway stenosis, irrespective of prior COVID-19 status.
Background:
The aims of this study were to evaluate the results of endoscopic dilation for simple benign airway stenosis in coronavirus disease 2019 (COVID-19) patients and whether COVID-19 infection was associated with higher rate of recurrence compared with a control group.
Methods:
It was an observational multicenter study including consecutive patients with simple benign airway stenosis undergoing endoscopic dilatation with at least 6 months of follow-up. The outcome of patients with COVID-19 infection was compared with that of a control group in relation to patient and stenosis characteristics, and procedure type. Then, univariable and multivariable analyses identified the risk factors for recurrence.
Results:
Seventy-nine patients were included in the study; 56 (71%) of these developed airway stenosis after COVID-19 infection. COVID-19 patients presented a higher rate of stenosis due to prolonged intubation (82 vs. 43%; p = 0.0014); no other differences were found regarding demographic data, characteristics of stenosis, and procedure type. Twenty-four (30%) patients had recurrence after first dilatation (32% for No-COVID-19 vs. 26% for COVID-19 group; p = 0.70), and in 11 (35%) of these, the stenosis recurred after repeated endoscopic treatment (65% for No-COVID-19 vs. 45% for COVID-19 group; p = 0.40). Subglottic stenosis (p = 0.013) and the use of laser (p = 0.016) were significant predictive factors for stenosis recurrence.
Conclusion:
COVID-19 infection did not affect the outcome of endoscopic treatment of simple airway stenosis, and the treatment of these subsets of patients should not differ from that of general population.
Related Concept Videos
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Trachea
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of...
Endotracheal Intubation I: Procedure
The ET tube comprises various components, including a standard adaptor to attach a bag-valve-mask (BVM) or ventilator, a cuff, a pilot balloon, and radiopaque markings along its length to measure the insertion distance. The tube sizes...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation

